Press releases
- Kezar Life Sciences to Participate in the Jefferies Global Healthcare Conference
- Kezar Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update
- Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
- Kezar Life Sciences Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Update
More ▼
Key statistics
On Monday, Kezar Life Sciences Inc (2KZ:DEU) closed at 0.64, 48.84% above the 52 week low of 0.43 set on May 31, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.446 |
---|---|
High | 0.645 |
Low | 0.446 |
Bid | 0.625 |
Offer | 0.66 |
Previous close | 0.62 |
Average volume | 890.20 |
---|---|
Shares outstanding | 72.80m |
Free float | 62.00m |
P/E (TTM) | -- |
Market cap | 50.52m USD |
EPS (TTM) | -1.40 USD |
Data delayed at least 15 minutes, as of Jun 03 2024.
More ▼